TCL Archive Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease June 29, 2012
TCL Archive NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It January 24, 1986
TCL Archive Simmonds Succeeds Young As ACS President; Lame-Duck Session Unlikely To Approve Funding Bills November 8, 2002
TCL Archive UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says September 24, 1999
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
